Related Experiment Video
Updated: Sep 30, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[Surgical treatment and prognosis of pulmonary metastasis]
Ruheng Zheng1, Di Ge, Meixin Shi
1Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Objective:
To study the surgical treatment and the prognosis of pulmonary metastasis.
Methods:
59 patients in the operative group and 36 patients in the control group were included. Their clinical data were collected by follow-up investigation and the prognosis was analyzed by stepwise regression.
Results:
The median survival time was 20.2 (operative group) and 10.0 (control group) months. The 1, 3 and 5-year survival rates in the two groups were 70%, 39%, 34% (operative group) and 28%, 8%, 0% (control group) respectively. The 5-year survival rate of patients with disease-free interval (DFI) < 1 year was 21%, while that of patients with DFI >/= 1 year was 40%.
Conclusions:
Resection of pulmonary metastasis should be considered if indicated. DFI is an important prognostic factor for pulmonary metastasis.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...